Back
PetMed Express 10K Form
Sell
45
PETS
PetMed Express
Last Price:
4.21
Seasonality Move:
9.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-15 | 10Q | PETS/PetMed Express Quarterly |
2023-10-31 | 10Q | PETS/PetMed Express Quarterly |
2023-08-02 | 10Q | PETS/PetMed Express Quarterly |
2023-02-07 | 10Q | PETS/PetMed Express Quarterly |
2022-11-08 | 10Q | PETS/PetMed Express Quarterly |
2022-08-02 | 10Q | PETS/PetMed Express Quarterly |
Receive PETS News And Ratings
See the #1 stock for the next 7 days that we like better than PETS
PETS Financial Statistics
Sales & Book Value
Annual Sales: | $281.06M |
---|---|
Cash Flow: | $-9.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.54 |
Price / Book: | 0.92 |
Profitability
EPS (TTM): | -0.17340 |
---|---|
Net Income (TTM): | $-3.36M |
Gross Margin: | $78.65M |
Return on Equity: | -3.22% |
Return on Assets: | -2.01% |
PetMed Express Earnings Forecast
Key PetMed Express Financial Ratios
- The Gross Profit Margin over the past 25 years for PETS is 27.98%.
- The Selling, General & Administrative Expenses for PETS have been equal to 28.38% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of PETS is -2.66% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 15 years.
PetMed Express Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Specialty Retail |
Sector: | Consumer Discretionary |
Current Symbol: | PETS |
CUSIP: | 716382 |
Website: | petmeds.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.33 |
Quick Ratio: | 0.83 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
PETS Technical Analysis vs Fundamental Analysis
Sell
45
PetMed Express (PETS)
is a Sell
Is PetMed Express a Buy or a Sell?
-
PetMed Express stock is rated a Sell
The current PetMed Express [PETS] share price is $4.19. The Score for PETS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.